The possible association between in vitro fertilization treatments and cancer development

International Journal of Gynecological Cancer

Volumn 13, Issue 1, 2003, Pages 23-27

  Lerner Geva, Liat ^a   Geva, E ^b   Lessing, J B ^b   Chetrit, A ^a   Modan, B ^c   Amit, A ^b  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b LIS MATERNITY HOSPITAL   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; In vitro fertilization; Infertility; Ovulation induction

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CARCINOGENESIS; CARCINOGENIC ACTIVITY; COHORT ANALYSIS; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

ADULT; FEMALE; FERTILIZATION IN VITRO; HUMANS; INCIDENCE; NEOPLASMS; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; RISK;

EID: 0344406824     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13041.x     Document Type: Article

References (33)

1. Atlas M, Menczer J. Massive hyperstimulation and borderline carcinoma of the ovary. A possible association. Acta Obstet Gynecol Scand 1982;61:261-3.
2. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br J Obstet Gynaecol 1982;89:962-4.
3. Ben-Hur H, Dgani R, Lancet M, Katz Z, Nissim F, Rosenman D. Ovarian carcinoma masquerading as ovarian hyperstimulation syndrome. Acta Obstet Gynecol Scand 1986;65:813-4.
4. Dietl J. Ovulation and ovarian cancer. Lancet 1991;338:445.
5. Kulkarni R, McGarry JM. Follicular stimulation and ovarian cancer. BMJ BMI 1989;299:740.
6. Ron E, Lunenfeld B, Menczer J et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780-90.
7. Blankstein J, Shalev J, Saadon T et al. Ovarian hyperstimulation syndrome, prediction by number and size of preovulatory ovarian follicles. Fertil Steril 1987;47:597-602.
8. Hack M, Brish M, Serr DM, Insler V, Lunenfeld B. Outcome of pregnancy after induced ovulation. Follow-up of pregnancies and children born after gonadotropin therapy. JAMA 1970;211:791-7.
9. Whittemore AS, Harris R, Intyre J. Characteristics relating to ovarian cancer risk. collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1184-203.
10. Harris R, Whittemore AS, Intyre J. Characteristics relating to ovarian cancer risk. collaborative analysis of 12 US case-control studies. III. Epithelial tumors of low malignant potential in white women. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992;136:1204-11.
11. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994;331:771-6.
12. Shushan A, Paltiel O, Ischovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996;65:13-8.
13. Modan B, Ron E, Lerner-Geva L et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998;147:1038-42.
14. Carter ME, Joyce DN. Ovarian carcinoma in a patient hyperstimulated by gonadotropin therapy for in vitro fertilization: a case report. J In Vitro Fert Embryo Transf 1987;4:126-8.
15. Fishel S, Jackson P. Follicular stimulation for high tech pregnancies: are we playing it safe? BMJ 1989;299:309-11.
16. Nijman HW, Burger CW, Baak JPA, Schats R, Vermorken JB, Kenemans P. Borderline malignancy of the ovary and controlled hyperstimulation. A report of two cases. Eur J Cancer 1992;28:1971-3.
17. Grimbizis G, Tarlatzis BC, Bontis J et al. Two cases of ovarian tumors in women who had undergone multiple ovarian stimulation attempts. Human Reprod 1995;10:520-3.
18. Shoham Z. Epidemiology, etiology and fertility drugs in ovarian epithelial carcinoma: Where are we today? Fertil Steril 1994;62:433-48.
19. Goshen R, Weissman A, Shoham Z. Epithelial ovarian cancer, infertility and induction of ovulation: possible pathogenesis and updated concepts. Baillieres Clin Obstet Gynaecol 1998;12:581-91.
20. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in-vitro fertilization. Lancet 1995;346:995-1000.
21. Venn A, Watson L, Bruinsma F, Giles G, Healy D. Risk of cancer after use of fertility drugs with in-vitro fertilization. Lancet 1999;354:1586-90.
22. Dor J, Lerner-Geva L, Rabinovici J, Chetrit A, Levran D, Lunenfeld B, Mashiach S, Modan B. Cancer incidence in a cohort of infertile women treated with in-vitro fertilization. Fertil Steril 2002;77:324-7.
23. Vardi G, Modan B, Golan R, Novikov I, Shafir R. Orthodox Jews have a lower incidence of malignant melanoma. A note on the potentially protective role of traditional clothing. Int J Cancer 1993;53:771-3.
24. Rothman KJ, Boice JD Jr. Epidemiologic analysis with a programmable calculator. Washington DC. GPO 1979 (DHEW Publication no. (NIH) 79-1649).
25. Mosgaard BJ, Lidegaard O, Kjaer SK, Schou G, Andersen AN. Infertility, fertility drugs and invasive ovarian cancer: a case-control study. Fertil Steril 1997; 67:1005-12.
26. Potashnik G, Lerner-Geva L, Genkin L, Chetrit A, Lunenfeld E, Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 1999;71:853-9.
27. Parazzini F, Pelucchi C, Negri E et al. Use of fertility drugs and risk of ovarian cancer. Hum Reprod 2001;16:1372-5.
28. Brinton LA, Melton LJ, Malkasian GD, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712-22.
29. Sawaya GF, Harper C, Balistreri E, Boggess J, Darney P. Cervical neoplasia risk in women provided hormonal contraception without a Pap smear. Contraception 2001;63:57-60.
30. Tasker M, Langley FA. The outlook for women with borderline epithelial tumours of the ovary. Br J Obstet Gynaecol 1985;92:969-73.
31. Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL. Conservative treatment of borderline ovarian tumors. Obstet Cynecol 1985;66:417-22.
32. Navot D, Williams M, Brodman M, Friedman F Jr, Cohen CJ. The concept of uterine preservation with ovarian malignancies. Obstet Cynecol 1991;78:566-8.
33. Beiner ME, Gotlieb WH, Davidson B, Kopolovic J, Ben-Baruch G. Infertility treatment after conservative management of borderline ovarian tumors. Cancer 2001;92:320-5.